Trust Company’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92K Sell
30
-5
-14% -$329 ﹤0.01% 548
2026
Q1
$2.49K Sell
35
-259
-88% -$20.4K ﹤0.01% 514
2025
Q4
$24.1K Buy
294
+267
+989% +$20.8K ﹤0.01% 363
2025
Q3
$2.03K Hold
27
﹤0.01% 366
2025
Q2
$2K Hold
27
﹤0.01% 381
2025
Q1
$2.18K Hold
27
﹤0.01% 402
2024
Q4
$2.11K Sell
27
-22
-45% -$1.87K ﹤0.01% 386
2024
Q3
$4.6K Hold
49
﹤0.01% 317
2024
Q2
$3.82K Sell
49
-151
-76% -$12.3K ﹤0.01% 308
2024
Q1
$18.2K Hold
200
﹤0.01% 258
2023
Q4
$15.5K Buy
200
+41
+26% +$2.87K ﹤0.01% 254
2023
Q3
$10.8K Hold
159
﹤0.01% 263
2023
Q2
$12.9K Buy
+159
New +$12.7K ﹤0.01% 260

Other funds holding GEHC

Trust Company's GEHC Position: Q2 2026 in Review

Trust Company reduced its GE HealthCare (GEHC) stake by 14% in Q2 2026, selling an estimated $329 and leaving 30 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Trust Company first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $24.1K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Trust Company held 30 shares of GE HealthCare worth $1.92K as of Q2 2026.
  • Trust Company sold 5 GE HealthCare shares in Q2 2026, an estimated $329.
  • GE HealthCare made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #548 holding.
  • Trust Company first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Trust Company's GE HealthCare position peaked at $24.1K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.